Northwire Canada EditionSaturday, October 17, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
M&A / Property

Rocket Doctor AI Completes Acquisition of Alea Health to Expand Access to Therapist-Led Mental Health Care

AIDR · Price

Executive Summary

  • Rocket Doctor AI Inc. completed the acquisition of Alea Health Holdings Ltd., issuing cash and 285,712 common shares as consideration.
  • The transaction also includes repayment of a US $180,000 SAFE Note in monthly installments, with the first payment made at closing.
  • Integration of Alee’s technology is expected to enhance Rocket Doctor AI’s AI‑driven clinical workflow and expand access to physician‑led digital health services across North America.

Key Details

  • Consideration Paid:
  • US $15,000 cash (previously paid as a deposit).
  • 285,712 Rocket Doctor AI common shares issued to Alea shareholders at a deemed value of CAD $0.70 per share.
  • SAFE Note Assumption:
  • Principal balance of US $180,000 to be repaid in equal monthly installments of US $22,500 until fully satisfied.
  • First installment paid concurrently with the closing of the transaction.
  • Share Issuance Terms:
  • Shares issued under National Instrument 45‑106 prospectus exemptions; subject to a statutory hold period of four months and one day.
  • Consideration shares placed in escrow with a 28‑month release schedule – 20 % released every four months beginning on the first anniversary of closing.
  • No Long‑Term Liabilities Assumed: Apart from the SAFE Note, Rocket Doctor AI did not assume any other long‑term liabilities of Alea.
  • Strategic Rationale: Acquisition adds complementary AI and decision‑support capabilities, strengthening Rocket Doctor AI’s platform for physician‑led virtual/hybrid care and expanding service reach to underserved communities in Canada and the United States.

Notable Quotes

“This acquisition represents an important step forward in executing our strategy to build a scalable, physician‑led digital health ecosystem,” – Dr. Essam Hamza, CEO, Rocket Doctor AI.

“Joining Rocket Doctor AI allows Alea’s technology to scale within a broader clinical and operational framework that is deeply aligned with our original mission,” – Richard Dallala, Founder & CEO, Alea Health.

Read the original news release →

More from Rocket Doctor AI Inc.